Latest News

Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for substance use disorders and other central nervous system disorders, has completed a funding round of $5m to enable continued development of the company’s development programs.

Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the European Respiratory Journal

Australian probiotic brand PERKii is excited to launch its new 100% plant-based Sparkling Probiotic Drinks into Coles Express stores nationally.

“The ultra-long range and massive capacity of our Wi-Fi HaLow technology along with its ultra-low-power is a game changer for the IoT.”

Uniseed has increased its stake in Australian biotechnology company Ena Respiratory which is developing a potentially landmark preventive treatment for COVID-19.

Latest investment takes total Series A funding to US $30 million to further develop its Wi-Fi HaLow technology and ramp customer designs

Leading custom compounder RTP Co. has acquired the patents for anti-scratch additives from Uniseed investee TenasiTech.

Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study

A four-part article on Uniseed’s journey over the past 20 years.  Each week in September, we will post a chapter covering the subsequent 5 years in Uniseed’s journey. Part 1 - 2000 - 2005 Part 2 - 2006 - 2010 Part 3 - 2011 - 2015 Part 4 - 2016 - 2020

Uniseed CEO Peter Devine talks with Global University Venturing’s Thierry Heles about Uniseed’s journey over the past 20 years.